SMART - is it practical in the United States?
Matthew R Norris, Sunjay Modi, Taha Al-Shaikhly
https://pubmed.ncbi.nlm.nih.gov/35131990/Actively Recruiting
Led by Washington University School of Medicine · Updated on 2026-09-10
2000
Participants Needed
7
Research Sites
52 weeks
Total Duration
Researchers are studying ways to improve asthma care in community health centers by helping clinicians prescribe a guideline-recommended treatment called SMART Single Maintenance and Reliever Therapy. This study uses a stepped-wedge cluster randomized design with six clinics transitioning from usual care to using the SMART implementation bundle. The goal is to see how well this program helps clinicians prescribe SMART therapy and whether it reduces asthma flare-ups in patients with moderate to severe asthma. The intervention includes clinician education with ongoing support, regular feedback on inhaler prescribing patterns, workflow integration assistance, and patient education tools like videos and asthma action plans designed for those with low health literacy. The study has three phases a pre-implementation phase to gather baseline data without intervention, an active implementation phase where the SMART bundle is introduced, and a sustainment phase to assess how well the program continues and spreads after full implementation. Participants include clinics, clinicians, staff, and patients aged 12 years and older with moderate to severe asthma. Researchers will monitor prescribing patterns, asthma outcomes, and the reach and effectiveness of the SMART bundle through data collection over up to 24 months. The study also evaluates clinician adherence and fidelity to the program, safety of SMART therapy, and cost impact while providing ongoing access to patient education materials beyond the intervention period.
CONDITIONS
CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
J
James Krings, MD MSCI
K
Krutika Chauhan, MBBS MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Washington University School of Medicine
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | SMART implementation bundle (study intervention) | Control (no intervention) |
|---|---|---|
| What it is | A multi‑component implementation strategy supporting clinics, clinicians, staff, and patients in adopting SMART asthma management | Usual care without additional implementation support for SMART |
| Role in trial | Assigned condition delivering education, audit and feedback, workflow integration, and patient tools | Assigned condition receiving no implementation bundle |
| Primary use | To support adoption and prescribing of SMART in clinics | Continuation of usual care without implementation support |
| How it is done | Delivered via clinician education sessions, audit and feedback reports, workflow integration support, and patient educational tools | Clinic continues routine care without added implementation activities |
| Evidence status | Efficacy under investigation; trial will measure adoption of SMART prescribing | Usual care – baseline for comparison |
| Important risks | No direct patient‑level risks expected from implementation activities | Standard care – no additional risks beyond routine care |
| Important limitations | Effectiveness may depend on clinic resources and provider engagement; crossover design may introduce carryover effects | May not reflect longer‑term adoption without supportive interventions |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to several months before implementation
Clinics continue usual asthma care while baseline data on prescribing patterns and asthma outcomes are collected without active intervention.
Data collection during routine visits
Duration - Up to 24 months
Clinicians and staff receive education, feedback, workflow support, and patient education tools to help adopt SMART therapy.
Quarterly practice facilitation and feedback visits
Duration - Up to 24 months after active implementation
Evaluations are conducted to assess how well the SMART implementation bundle is maintained and disseminated after full rollout.
Periodic assessments and dissemination activities
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Matthew R Norris, Sunjay Modi, Taha Al-Shaikhly
https://pubmed.ncbi.nlm.nih.gov/35131990/Noah Ivers, Gro Jamtvedt, Signe Flottorp...
https://pubmed.ncbi.nlm.nih.gov/22696318/Sandra E Zaeh, Zoe E Zimmerman, Michelle N Eakin...
https://pubmed.ncbi.nlm.nih.gov/38897404/James G Krings, Tejas C Sekhar, Vanessa Chen...
https://pubmed.ncbi.nlm.nih.gov/37245736/Kenneth R Chapman, Neil C Barnes, Andrew P Greening...
https://pubmed.ncbi.nlm.nih.gov/20581409/Alexander F Infante, Christina Wells, Julie Loza...
https://pubmed.ncbi.nlm.nih.gov/39455262/Helen K Reddel, Eric D Bateman, Michael Schatz...
https://pubmed.ncbi.nlm.nih.gov/34666208/Washington University School of Medicine
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor